Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion type Assertion NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_head.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion description "[This review summarizes the role of EphA2 in tumorigenesis and the development of EphA2 receptor antagonists as candidate anti-cancer agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_provenance.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion evidence source_evidence_literature NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_provenance.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion SIO_000772 21933105 NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_provenance.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion wasDerivedFrom befree-2016 NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_provenance.
- NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_assertion wasGeneratedBy ECO_0000203 NP925077.RAqR7Kv3CKpDt5xqmu0FrHOKqTgYFjsp-8uf21xV_VgSQ130_provenance.